VXRT 8-K 2026-10-19

Vaxart, Inc. (VXRT) 8-K dated 2026-10-19 — accession 0001437749-26-032932. This URL is the filing, not the VXRT hub.

Vaxart, Inc. (VXRT) is a biotechnology company listed on US.

Vaxart, Inc. filed a 8-K on 2026-10-19. Accession 0001437749-26-032932.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VXRT revenue for 2025-12-31 was $237.3M. Net income was $16.3M. Revenue was up 726.7% from 2024-12-31 to 2025-12-31. VXRT currently screens at market cap $73.0M.

Not investment advice. The VXRT SEC hub lists recent forms. The stock page is the research view.